Endurant Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $448K | Sell |
|
|||||
|
2023
Q3 | $15.9M | Buy |
|
|||||
|
2023
Q2 | $3.78M | Sell |
|
|||||
|
2023
Q1 | $24.9M | Buy |
|
|||||
|
2022
Q4 | $8.73M | Sell |
|
|||||
|
2022
Q3 | $12.3M | Buy |
|
|||||
|
2022
Q2 | $2.15M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.42M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $901K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $845K | Buy |
|
|||||
|
2017
Q1 | $448K | Buy |
|